FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
CipherOx CRI Tablet
K Number: K213255
·
Decision Jun 17, 2022
Classifications
1
FEI Numbers
3
Registration Numbers
3
Same Product Code
7
Applicant Total
3
Review Days
260
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- CipherOx CRI Tablet
- K Number
- K213255
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 870.2200
- Medical Specialty
- Cardiovascular
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Flashback Technologies, Inc.
- Date Received
- September 30, 2021
- Decision Date
- June 17, 2022
- Product Code
- PPW
- Advisory Committee
- Cardiovascular
- Review Advisory Committee
- CV
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| PPW | Adjunctive Cardiovascular Status Indicator | FDA class 2 | Cardiovascular |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (PPW), ordered by most recent decision date.
Etiometry Platform
FDA 510(k)
FDA Class 2
·Cardiovascular
prolaio eVO2peak Module (Version 1.0)
FDA 510(k)
FDA Class 2
·Cardiovascular
Etiometry Platform (DAV 5.4 RAE 9.2)
FDA 510(k)
FDA Class 2
·Cardiovascular
T3 Platform software
FDA 510(k)
FDA Class 2
·Cardiovascular
T3 Platform Software
FDA 510(k)
FDA Class 2
·Cardiovascular
CipherOx CRI M1
FDA 510(k)
FDA Class 2
·Cardiovascular